April 26, 2016
(Medical News Today) – It is well established that the acne medication isotretinoin – brand name Accutane – can cause severe harm to a developing fetus, which is why pregnancy prevention guidelines are in place for its use. A new study, however, suggests many women are not adhering to such guidelines. Published in the CMAJ, the study suggests up to 50 percent of women in Canada taking isotretinoin do not comply with the country’s current guidelines for use of the drug, resulting in birth defects, miscarriages and pregnancy terminations.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.